QuantaMatrix: QuantaMatrix to match up $71.8m IPO - Global University Venturing
QuantaMatrix is targeting $17.80 to $22.30 per share under a regulation permitting a listing on the basis of growth and technology potential.
Read full article »
QuantaMatrix develops and commercializes molecular and cellular based drugs for the treatment of Tuberculosis, infectious disease and cancer.
Read more